HORDB

ID: hd00033
Active Ingredients: Buserelin
DRUGBANK Accession Number: DB06719
Active Sequence: XHWSYXLRP
Sequence Length: 9
Type: Biotech
Description: Buserelin is a synthetic peptide analog of the luteinizing hormone-releasing hormone (LHRH) agonist, which stimulates the pituitary gland's gonadotrophin-releasing hormone receptor (GnRHR). It is used in prostate cancer treatment.
Disease: Prostate cancer; endometriosis; assisted reproduction
CAS: 57982-77-1
SMILES: CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6

Drug Name	Strength	Dosage Form/Route	Company	Marketing Status	Approval year
SUPREFACT LIQ 1MG/ML	1 MG/ML	SPRAY, METERED; NASAL	HOECHST ROUSSEL CANADA INC.	Discontinued	1993
SUPREFACT LIQ 1MG/ML	1 MG/ML	SPRAY, METERED; NASAL	HOECHST ROUSSEL CANADA INC.	Discontinued	1993
SUPREFACT LIQ 1MG/ML	1 MG/ML	SPRAY, METERED; NASAL	HOECHST ROUSSEL CANADA INC.	Discontinued	1993
SUPREFACT LIQ 1MG/ML	1 MG/ML	SPRAY, METERED; NASAL	HOECHST ROUSSEL CANADA INC.	Discontinued	1993
SUPREFACT LIQ 1MG/ML	1 MG/ML	SPRAY, METERED; NASAL	HOECHST ROUSSEL CANADA INC.	Discontinued	1993
SUPREFACT LIQ 1MG/ML	1 MG/ML	SPRAY, METERED; NASAL	HOECHST ROUSSEL CANADA INC.	Discontinued	1993
SUPREFACT LIQ 1MG/ML	1 MG/ML	SPRAY, METERED; NASAL	HOECHST ROUSSEL CANADA INC.	Discontinued	1993